 |
|
Human Dysbindin (DTNBP1) Gene Expression in Normal Brain and in Schizophrenic Prefrontal Cortex and Midbrain
Cynthia Shannon Weickert, PhD;
Richard E. Straub, PhD;
Benjamin W. McClintock, BA;
Mitsuyuki Matsumoto, PhD;
Ryota Hashimoto, MD, PhD;
Thomas M. Hyde, MD, PhD;
Mary M. Herman, MD;
Daniel R. Weinberger, MD;
Joel E. Kleinman, MD, PhD
Arch Gen Psychiatry. 2004;61:544-555.
Context The schizophrenia-susceptibility gene dysbindin (DTNBP1 on 6p22.3) encodes a neuronal protein that binds to  -dystrobrevin and may be part of the dystrophin protein complex. Little is known about dysbindin expression in normal or schizophrenic brain.
Objectives To determine whether brain regions implicated in schizophrenia express dysbindin and whether abnormal levels of dysbindin messenger RNA (mRNA) may be found in this disorder and to test whether sequence variations in the dysbindin gene in the promoter region, 5' and 3' untranslated regions, or introns would affect dysbindin mRNA levels.
Methods In patients with schizophrenia and controls, we compared dysbindin, synaptophysin, spinophilin, and cyclophilin mRNA levels in the dorsolateral prefrontal cortex and dysbindin mRNA levels in the midbrain by in situ hybridization. We genotyped brain DNA at 11 single nucleotide polymorphisms to determine whether genetic variation in the dysbindin gene affects cortical dysbindin mRNA levels.
Main Outcome Measures Quantitative assessment of dysbindin mRNA levels across various brain regions and comparative studies of dysbindin mRNA levels in brains of patients with schizophrenia compared with normal controls.
Results Dysbindin mRNA was detected in the frontal cortex, temporal cortex, hippocampus, caudate, putamen, nucleus accumbens, amygdala, thalamus, and midbrain of the adult brain. Patients with schizophrenia had statistically significantly reduced dysbindin mRNA levels in multiple layers of the dorsolateral prefrontal cortex, whereas synaptophysin, spinophilin, and cyclophilin mRNA levels were unchanged. Dysbindin mRNA levels were quantitatively reduced in the midbrain of patients with schizophrenia, but not statistically significantly. Cortical dysbindin mRNA levels varied statistically significantly according to dysbindin genotype.
Conclusions Dysbindin mRNA is expressed widely in the brain, and its expression is reduced in schizophrenia. Variation in dysbindin mRNA levels may be determined in part by variation in the promoter and the 5' and 3' untranslated regions. These data add to the evidence that dysbindin is an etiologic factor in schizophrenia risk.
From the Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Md (Drs Weickert, Straub, Hyde, Herman, Weinberger, and Kleinman, and Mr McClintock); Department of Genomics Research, Yamanouchi Pharmaceutical Co, Ibaraki, Japan (Dr Matsumoto); and Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan (Dr Hashimoto).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework
Pearlson and Folley
Schizophr Bull 2008;34:722-733.
ABSTRACT
| FULL TEXT
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
Chen et al.
J. Cell Biol. 2008;181:791-801.
ABSTRACT
| FULL TEXT
Gene Expression in the Etiology of Schizophrenia
Bray
Schizophr Bull 2008;34:412-418.
ABSTRACT
| FULL TEXT
Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1
Bray et al.
Hum Mol Genet 2008;17:1169-1174.
ABSTRACT
| FULL TEXT
Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization
Iizuka et al.
J. Neurosci. 2007;27:12390-12395.
ABSTRACT
| FULL TEXT
Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice
Eastwood et al.
J Psychopharmacol 2007;21:635-644.
ABSTRACT
Schizophrenia: a common disease caused by multiple rare alleles
McClellan et al.
Br. J. Psychiatry 2007;190:194-199.
ABSTRACT
| FULL TEXT
Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin
Talbot et al.
Hum Mol Genet 2006;15:3041-3054.
ABSTRACT
| FULL TEXT
Schizophrenia Susceptibility Genes: Emergence of Positional Candidates and Future Directions
Gogos and Gerber
Focus 2006;4:369.
ABSTRACT
| FULL TEXT
Genetic Heterogeneity, Modifier Genes, and Quantitative Phenotypes in Psychiatric Illness: Searching for a Framework
Fanous and Kendler
Focus 2006;4:423.
ABSTRACT
| FULL TEXT
Genetic variation in DTNBP1 influences general cognitive ability
Burdick et al.
Hum Mol Genet 2006;15:1563-1568.
ABSTRACT
| FULL TEXT
Dysbindin Genotype and Negative Symptoms in Schizophrenia
DeRosse et al.
Am. J. Psychiatry 2006;163:532-534.
ABSTRACT
| FULL TEXT
Relationship Between a High-Risk Haplotype in the DTNBP1 (Dysbindin) Gene and Clinical Features of Schizophrenia
Fanous et al.
Am. J. Psychiatry 2005;162:1824-1832.
ABSTRACT
| FULL TEXT
Is the Dysbindin Gene (DTNBP1) a Susceptibility Gene for Schizophrenia?
Williams et al.
Schizophr Bull 2005;31:800-805.
ABSTRACT
| FULL TEXT
Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression
Bray et al.
Hum Mol Genet 2005;14:1947-1954.
ABSTRACT
| FULL TEXT
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock et al.
J. Med. Genet. 2005;42:193-204.
ABSTRACT
| FULL TEXT
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
Numakawa et al.
Hum Mol Genet 2004;13:2699-2708.
ABSTRACT
| FULL TEXT
Schizophrenia Genetics and Dysbindin: A Corner Turned?
Kendler
Am. J. Psychiatry 2004;161:1533-1536.
FULL TEXT
|
